178 related articles for article (PubMed ID: 17550218)
21. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
Skuza KA; Sills IN; Stene M; Rapaport R
J Pediatr; 1996 Feb; 128(2):264-8. PubMed ID: 8636826
[TBL] [Abstract][Full Text] [Related]
22. A hypothyroid mother after subtotal thyroidectomy delivered a newborn with hyperthyroidism from fetal stage: a case report.
Peng C; Sun W; Fan L; Li L; Zhang X; Gao Y; Hou X
BMC Pregnancy Childbirth; 2022 Apr; 22(1):312. PubMed ID: 35413827
[TBL] [Abstract][Full Text] [Related]
23. [Characterization of children born to mothers with Graves' disease].
Muñoz Pérez T; Peña Manubens MF; Román Reyes R; Riquelme Romero J
Andes Pediatr; 2021 Aug; 92(4):556-564. PubMed ID: 34652374
[TBL] [Abstract][Full Text] [Related]
24. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
[TBL] [Abstract][Full Text] [Related]
25. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
26. [Neonatal hyperthyroidism in a premature infant born to a mother with Grave's disease].
Nicaise C; Gire C; Brémond V; Minodier P; Soula F; d'Ercole C; Palix C
Arch Pediatr; 2000 May; 7(5):505-8. PubMed ID: 10855389
[TBL] [Abstract][Full Text] [Related]
27. Neonatal thyrotoxicosis treated with exchange transfusion and Lugol's iodine.
Wit JM; Gerards LJ; Vermeulen-Meiners C; Bruinse HW
Eur J Pediatr; 1985 Mar; 143(4):317-9. PubMed ID: 2859196
[TBL] [Abstract][Full Text] [Related]
28. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
[TBL] [Abstract][Full Text] [Related]
29. Prolonged suppressed thyroid-stimulating hormone levels in hyperthyroidism in a neonate born to a mother with Graves' disease.
Hojo M; Momotani N; Ikeda N; Ueda A; Uno K; Ishikita T; Ishiguro A; Shimbo T
Acta Paediatr Jpn; 1998 Oct; 40(5):483-5. PubMed ID: 9821712
[TBL] [Abstract][Full Text] [Related]
30. Management of thyrotoxicosis during pregnancy.
Andersen SL; Knøsgaard L
Best Pract Res Clin Endocrinol Metab; 2020 Jul; 34(4):101414. PubMed ID: 32199749
[TBL] [Abstract][Full Text] [Related]
31. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
32. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Nachum Z; Rakover Y; Weiner E; Shalev E
Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy.
Yoshihara A; Iwaku K; Noh JY; Watanabe N; Kunii Y; Ohye H; Suzuki M; Matsumoto M; Suzuki N; Tadokoro R; Sekiyama C; Hiruma M; Sugino K; Ito K
Thyroid; 2019 Jan; 29(1):128-134. PubMed ID: 30426886
[TBL] [Abstract][Full Text] [Related]
34. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
35. Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease.
Calissendorff J; Falhammar H
Endocrine; 2017 Dec; 58(3):467-473. PubMed ID: 29075974
[TBL] [Abstract][Full Text] [Related]
36. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of oral iodide therapy on neonatal hyperthyroidism caused by maternal Graves' disease.
Maragliano G; Zuppa AA; Florio MG; Scapillati ME; Girlando P; Crescimbini B; Cafforio C; Noia G; Cavaliere AF; Tortorolo G
Fetal Diagn Ther; 2000; 15(2):122-6. PubMed ID: 10720879
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and course of thyroid dysfunction in neonates at high risk of Graves' disease or with non-autoimmune hyperthyroidism.
Benlarbi H; Simon D; Rosenblatt J; Dumaine C; de Roux N; Chevenne D; Storey C; Poidvin A; Martinerie L; Carel JC; Léger J
Eur J Endocrinol; 2021 Mar; 184(3):427-436. PubMed ID: 33465046
[TBL] [Abstract][Full Text] [Related]
39. Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report.
Kazakou P; Theodora M; Kanaka-Gantenbein C; Zapanti E; Bouza H; Petropoulou C; Daskalakis G; Paschou SA; Anastasiou E
Case Rep Womens Health; 2018 Oct; 20():e00081. PubMed ID: 30294557
[TBL] [Abstract][Full Text] [Related]
40. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
